SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-023834
Filing Date
2024-09-23
Accepted
2024-09-23 16:05:18
Documents
1
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 form3-09232024_080915.html 3  
1 form3-09232024_080915.xml 3 4312
  Complete submission text file 0001415889-24-023834.txt   5775
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address
TANG KEVIN (Reporting) CIK: 0001178579 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36421 | Film No.: 241316313

Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)